Harvard Bioscience, Inc. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/157485de-4dd1-4bc2-9b2e-bb6ee516a23d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-56.7M | 2025-01-01 – 2025-12-31 | evidence 0001171843-26-001548 |
| FY 2024 | $-12.4M | 2024-01-01 – 2024-12-31 | evidence 0001171843-25-001472 |
| FY 2023 | $-3.4M | 2023-01-01 – 2023-12-31 | evidence 0001171843-24-001239 |
| FY 2022 | $-9.5M | 2022-01-01 – 2022-12-31 | evidence 0001171843-23-001566 |
| FY 2021 | $-288.0k | 2021-01-01 – 2021-12-31 | evidence 0001171843-22-001806 |
| FY 2020 | $-7.8M | 2020-01-01 – 2020-12-31 | evidence 0001171843-21-001737 |
| FY 2019 | $-4.7M | 2019-01-01 – 2019-12-31 | evidence 0001171843-20-001755 |
| FY 2018 | $-2.9M | 2018-01-01 – 2018-12-31 | evidence 0001171843-19-001793 |
| FY 2017 | $-865.0k | 2017-01-01 – 2017-12-31 | evidence 0001171843-18-002041 |
| FY 2016 | $-4.3M | 2016-01-01 – 2016-12-31 | evidence 0001171843-17-001588 |
| FY 2015 | $-19.0M | 2015-01-01 – 2015-12-31 | evidence 0001171843-16-009551 |
| FY 2014 | $2.4M | 2014-01-01 – 2014-12-31 | evidence 0001171843-15-001376 |
| FY 2013 | $-1.8M | 2013-01-01 – 2013-12-31 | evidence 0001171843-14-001247 |
| FY 2012 | $2.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-112305 |
| FY 2011 | $3.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-116670 |
| FY 2010 | $19.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-116670 |
| FY 2009 | $7.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-116670 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Harvard Bioscience, Inc. — all facts · Revenue · Operating Income